Huan Yang

Company: Merck

Job title: Associate Principal Scientist

Seminars:

Engineering Allogeneic Gamma Delta T Cell Therapies: Opportunities & Challenges, Present & Tomorrow 4:45 pm

Exploring the specific challenges of approved CD3 engagers, to pinpoint gaps for gamma delta T to help, such as cytotoxicity Reviewing successes and lessons from other adoptive cell therapies and the potential for enhanced safety profiles, scalability, and indication-specific development with gamma delta T Discussing the future challenges to predict and remove obstacles to progress…Read more

day: Conference Day Two

Panel Discussion: What Needs to be Done to Fully Capitalize on the Promise of Genetic Engineering to Produce Scalable & Clinically Efficacious Gamma Delta T Cells? 4:15 pm

Debating the need for genetic engineering to enable strong clinical results Comparing and contrasting the need for CARs or other types of gene engineering to enhance efficacy Leveraging different engineering technologies to equip gamma delta Ts with the genetic capabilities to maximize persistenceRead more

day: Conference Day One